Atlas Trials

Dendritic Cell (DC) Activated Cytokine-induced Killer Cell (DCIK) Combined With DC Treatment for Glioma

Clinical trial NCT01235845 · UNKNOWN

Trial details

NCT number
NCT01235845
Sponsor
Qingdao University
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Malignant Glioma
Start date
2011-01-01
Primary completion
2012-12-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.